Exacerbation of Portal Hypertensive Enteropathy after Endoscopic Injection Sclerotherapy for Esophageal Varices | Zendy

Ichiro Otani | Zendy; Shiro Oka | Zendy; Hiroshi Aikata | Zendy; Sumio Iio | Zendy; Akiyoshi Tsuboi | Zendy; Sayoko Kunihara | Zendy; Yuko Nagaoki | Zendy; Shinji Tanaka | Zendy; Kazuaki Chayama | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Exacerbation of Portal Hypertensive Enteropathy after Endoscopic Injection Sclerotherapy for Esophageal Varices

Author(s) -

Ichiro Otani,

Shiro Oka,

Hiroshi Aikata,

Sumio Iio,

Akiyoshi Tsuboi,

Sayoko Kunihara,

Yuko Nagaoki,

Shinji Tanaka,

Kazuaki Chayama

Publication year - 2019

Publication title -

digestion

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.882

H-Index - 75

eISSN - 1421-9867

pISSN - 0012-2823

DOI - 10.1159/000503060

Subject(s) - medicine , sclerotherapy , exacerbation , gastroenterology , esophageal varices , cirrhosis , edema , portal hypertension , capsule endoscopy , portal hypertensive gastropathy , radiology

Portal hypertensive enteropathy (PHE) is a well-known small-bowel lesion that occurs with liver cirrhosis (LC) and is associated with increased hepatic venous pressure. However, it is unclear how esophageal varices (EV) treatment actually affects PHE. We aimed to analyze the effects of EV treatment on PHE.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research